Display options
Cite
Angsantikul P, Thamphiwatana S, Zhang Q, et al. Coating nanoparticles with gastric epithelial cell membrane for targeted antibiotic delivery against . Adv Ther (Weinh). 2018;1(2)doi: 10.1002/adtp.201800016.
Angsantikul, P., Thamphiwatana, S., Zhang, Q., Spiekermann, K., Zhuang, J., Fang, R. H., Gao, W., Obonyo, M., & Zhang, L. (2018). Coating nanoparticles with gastric epithelial cell membrane for targeted antibiotic delivery against . Advanced therapeutics, 1(2), . https://doi.org/10.1002/adtp.201800016
Angsantikul, Pavimol, et al. "Coating nanoparticles with gastric epithelial cell membrane for targeted antibiotic delivery against ." Advanced therapeutics vol. 1,2 (2018). doi: https://doi.org/10.1002/adtp.201800016
Angsantikul P, Thamphiwatana S, Zhang Q, Spiekermann K, Zhuang J, Fang RH, Gao W, Obonyo M, Zhang L. Coating nanoparticles with gastric epithelial cell membrane for targeted antibiotic delivery against . Adv Ther (Weinh). 2018 Jun;1(2). doi: 10.1002/adtp.201800016. Epub 2018 May 08. PMID: 30320205; PMCID: PMC6176867.
Copy Download .nbib Format: NLM
Share it on

Adv Ther (Weinh). 2018 Jun;1(2). doi: 10.1002/adtp.201800016. Epub 2018 May 08.

Coating nanoparticles with gastric epithelial cell membrane for targeted antibiotic delivery against .

Advanced therapeutics

Pavimol Angsantikul, Soracha Thamphiwatana, Qiangzhe Zhang, Kevin Spiekermann, Jia Zhuang, Ronnie H Fang, Weiwei Gao, Marygorret Obonyo, Liangfang Zhang

Affiliations

  1. Department of NanoEngineering and Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.
  2. Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.

PMID: 30320205 PMCID: PMC6176867 DOI: 10.1002/adtp.201800016

Abstract

Inspired by the natural pathogen-host interactions and adhesion, this study reports on the development of a novel targeted nanotherapeutics for the treatment of

Keywords: active targeting; antimicrobial delivery; bacterial infection; biomimetic nanoparticle; nanomedicine

Conflict of interest statement

Conflict of Interest The authors declare no conflict of interest.

References

  1. Cell Host Microbe. 2016 Jan 13;19(1):12-20 - PubMed
  2. Proc Natl Acad Sci U S A. 2012 Sep 4;109(36):14640-5 - PubMed
  3. Mol Pharm. 2012 Sep 4;9(9):2677-85 - PubMed
  4. Helicobacter. 2015 Sep;20 Suppl 1:8-16 - PubMed
  5. N Engl J Med. 2010 Apr 29;362(17):1597-604 - PubMed
  6. Curr Opin Infect Dis. 2017 Oct;30(5):489-497 - PubMed
  7. Adv Healthc Mater. 2018 Jul;7(13):e1701366 - PubMed
  8. Cell. 2006 Feb 24;124(4):715-27 - PubMed
  9. Langmuir. 2013 Oct 1;29(39):12228-33 - PubMed
  10. J Drug Target. 2015;23(7-8):619-26 - PubMed
  11. Infect Immun. 2002 Jun;70(6):3295-9 - PubMed
  12. Adv Mater. 2015 Jun 10;27(22):3437-43 - PubMed
  13. Helicobacter. 2016 Oct;21(5):349-63 - PubMed
  14. ACS Nano. 2017 Dec 26;11(12):11923-11930 - PubMed
  15. J Drug Target. 2008 Jan;16(1):65-72 - PubMed
  16. Tissue Eng Part B Rev. 2016 Dec;22(6):485-498 - PubMed
  17. Biomaterials. 2009 Jul;30(19):3332-42 - PubMed
  18. Gastroenterology. 2003 Dec;125(6):1613-25 - PubMed
  19. Adv Mater. 2015 Nov 25;27(44):7043-50 - PubMed
  20. J Mater Chem B. 2014 Dec 14;2(46):8201-8207 - PubMed
  21. Polymers (Basel). 2011 Sep 1;3(3):1377-1397 - PubMed
  22. Adv Drug Deliv Rev. 2009 Feb 27;61(2):158-71 - PubMed
  23. Nature. 2015 Oct 1;526(7571):118-21 - PubMed
  24. Cancer Gene Ther. 2015 Mar;22(2):67-71 - PubMed
  25. J Drug Target. 2003 Aug;11(7):415-23; discussion 423-4 - PubMed
  26. Nat Rev Gastroenterol Hepatol. 2010 Nov;7(11):629-41 - PubMed
  27. J R Soc Interface. 2014 Dec 6;11(101):20141040 - PubMed
  28. Nano Lett. 2014;14(4):2181-8 - PubMed
  29. FEBS J. 2017 Dec;284(23):4143-4157 - PubMed
  30. World J Gastroenterol. 2015 Dec 28;21(48):13432-7 - PubMed
  31. Anal Chem. 2011 Aug 15;83(16):6336-41 - PubMed
  32. Nat Rev Microbiol. 2006 Jun;4(6):445-57 - PubMed
  33. Small. 2015 Sep 9;11(34):4309-13 - PubMed
  34. Nat Rev Microbiol. 2013 Jun;11(6):385-99 - PubMed
  35. Expert Opin Pharmacother. 2015;16(15):2307-17 - PubMed
  36. Nat Rev Gastroenterol Hepatol. 2017 Apr;14(4):230-240 - PubMed
  37. Antimicrob Agents Chemother. 2003 Jul;47(7):2249-55 - PubMed
  38. Exp Ther Med. 2017 Dec;14(6):5678-5686 - PubMed
  39. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2014 Nov-Dec;6(6):532-47 - PubMed
  40. J Drug Target. 2009 Apr;17(3):225-34 - PubMed
  41. Nanomedicine (Lond). 2013 Aug;8(8):1271-80 - PubMed
  42. Nat Nanotechnol. 2013 May;8(5):336-40 - PubMed
  43. Antimicrob Agents Chemother. 2000 Oct;44(10):2623-9 - PubMed
  44. Proc Natl Acad Sci U S A. 2014 Dec 9;111(49):17600-5 - PubMed
  45. Nat Nanotechnol. 2013 Dec;8(12):933-8 - PubMed
  46. Proc Natl Acad Sci U S A. 2017 Oct 24;114(43):11488-11493 - PubMed
  47. Front Cell Infect Microbiol. 2017 May 05;7:168 - PubMed

Publication Types

Grant support